The global rise in endocrine and metabolic diseases presents a major public health challenge—driving demand for novel therapies that improve long-term outcomes and patient quality of life. At mediSMART, we are actively involved in the clinical development of innovative treatments across a wide range of endocrine and metabolic indications.

We conduct phase I–IV clinical trials in both adult and pediatric populations, with experience in areas such as:

🩸 Type 1 and Type 2 diabetes mellitus

⚖️ Obesity and weight management

🧪 Dyslipidemia

🦋 Thyroid disorders

🧬 Adrenal and pituitary disorders

👩‍⚕️ Polycystic ovary syndrome (PCOS)

📏 Growth hormone deficiencies and metabolic bone diseases

Our dedicated team of endocrinology investigators, coordinators, and project managers ensures the smooth execution of complex, data-driven trials—with a strong focus on regulatory compliance, patient safety, and timely data delivery.

With a growing footprint across Turkey and the MENA region, mediSMART provides sponsors with localized expertise and regional scalability to advance clinical research in this critical therapeutic area.